NOS2 and cancer: Therefore, despite the high concentration of K+ ions in tumors affecting the expression of Arg I and iNOS by MDSCs, these cells adapt and maintain their pathological immunomodulatory functions in the TME, as widely recognized in the literature from human and mouse cancer studies.